{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T23:41:11Z","timestamp":1649202071140},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.jocn.2006.08.012","type":"journal-article","created":{"date-parts":[[2007,12,26]],"date-time":"2007-12-26T08:55:52Z","timestamp":1198659352000},"page":"166-171","source":"Crossref","is-referenced-by-count":8,"title":["Anticoagulant usage for primary stroke prevention: A general practitioner survey in local areas of metropolitan Sydney"],"prefix":"10.1016","volume":"15","author":[{"given":"Qing","family":"Shen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"Cordato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jude","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wai Tak","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Kokkinos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Karr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel Kam","family":"Yin Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2006.08.012_bib1","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"key":"10.1016\/j.jocn.2006.08.012_bib2","doi-asserted-by":"crossref","first-page":"300S","DOI":"10.1378\/chest.119.1_suppl.300S","article-title":"Antithrombotic and thrombolytic therapy for ischemic stroke","volume":"119","author":"Albers","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.jocn.2006.08.012_bib3","unstructured":"Australian Bureau of Statistics. 2001 Census Usual Residents Profile, LGA 10350 Bankstown (C) (Local Government Area), Australia, New South Wales. Canberra: Australian Bureau of Statistics; 2001. www.abs.gov.au."},{"key":"10.1016\/j.jocn.2006.08.012_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000069934","article-title":"Long-term outcome after stroke due to atrial fibrillation","volume":"16","author":"Mattle","year":"2003","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.jocn.2006.08.012_bib5","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1161\/01.STR.0000166053.83476.4a","article-title":"Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study","volume":"36","author":"Marini","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.jocn.2006.08.012_bib6","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1161\/01.STR.27.10.1765","article-title":"Acute stroke with atrial fibrillation. The Copenhagen Stroke Study","volume":"27","author":"Jorgensen","year":"1996","journal-title":"Stroke"},{"key":"10.1016\/j.jocn.2006.08.012_bib7","doi-asserted-by":"crossref","unstructured":"Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449\u201357.","DOI":"10.1001\/archinte.154.13.1449"},{"key":"10.1016\/j.jocn.2006.08.012_bib8","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1161\/01.STR.32.1.280","article-title":"Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association","volume":"32","author":"Goldstein","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.jocn.2006.08.012_bib9","doi-asserted-by":"crossref","first-page":"492","DOI":"10.7326\/0003-4819-131-7-199910050-00003","article-title":"Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis","volume":"131","author":"Hart","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jocn.2006.08.012_bib10","doi-asserted-by":"crossref","first-page":"831","DOI":"10.7326\/0003-4819-138-10-200305200-00011","article-title":"Lessons from the Stroke Prevention in Atrial Fibrillation trials","volume":"138","author":"Hart","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jocn.2006.08.012_bib11","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1345\/aph.1C025","article-title":"Patient-specific factors predictive of warfarin dosage requirements","volume":"36","author":"Absher","year":"2002","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jocn.2006.08.012_bib12","first-page":"15","article-title":"Racial and ethnic differences in warfarin response","volume":"13","author":"El Rouby","year":"2004","journal-title":"J Heart Valve Dis"},{"key":"10.1016\/j.jocn.2006.08.012_bib13","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1345\/aph.1E566","article-title":"The influence of ethnicity on warfarin dosage requirement","volume":"39","author":"Dang","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jocn.2006.08.012_bib14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000081054","article-title":"Comparison of stroke risk factors and outcomes in English-speaking background versus non-English speaking background patients","volume":"24","author":"Shen","year":"2005","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.jocn.2006.08.012_bib15","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1054\/jocn.2001.1018","article-title":"The morbidity related to atrial fibrillation at a tertiary centre in one year: 9.0% of all strokes are potentially preventable","volume":"9","author":"Evans","year":"2002","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.jocn.2006.08.012_bib16","series-title":"Modern Applied Biostatistical Methods Using S-Plus","author":"Selvin","year":"1998"},{"key":"10.1016\/j.jocn.2006.08.012_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1445-5994.2002.00156.x","article-title":"Doctors\u2019 beliefs on the use of antithrombotic therapy in atrial fibrillation: identifying barriers to stroke prevention","volume":"32","author":"Peterson","year":"2002","journal-title":"Intern Med J"},{"key":"10.1016\/j.jocn.2006.08.012_bib18","first-page":"199","article-title":"Warfarin use in atrial fibrillation: A random sample survey of family physician beliefs and preferences","volume":"9","author":"Pradhan","year":"2002","journal-title":"Can J Clin Pharmacol"},{"key":"10.1016\/j.jocn.2006.08.012_bib19","first-page":"257","article-title":"Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation","volume":"21","author":"Anderson","year":"2005","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jocn.2006.08.012_bib20","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1161\/circ.104.17.2118","volume":"104","author":"Fuster","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jocn.2006.08.012_bib21","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jocn.2006.08.012_bib22","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1161\/01.CIR.0000145172.55640.93","article-title":"Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin","volume":"110","author":"Gage","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jocn.2006.08.012_bib23","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.7326\/0003-4819-139-12-200312160-00011","article-title":"Management of newly detected atrial fibrillation: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians","volume":"139","author":"Snow","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jocn.2006.08.012_bib24","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1161\/01.STR.31.6.1217","article-title":"Warfarin for stroke prevention still underused in atrial fibrillation: patterns of omission","volume":"31","author":"Cohen","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.jocn.2006.08.012_bib25","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/archinte.159.7.677","article-title":"Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls","volume":"159","author":"Man-Son-Hing","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jocn.2006.08.012_bib26","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1161\/01.STR.0000157947.89347.d8","article-title":"Stroke in the very elderly (multiple letters)","volume":"36","author":"Marti","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.jocn.2006.08.012_bib27","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2141.2004.05154.x","article-title":"Point of care testing for INR monitoring: where are we now?","volume":"127","author":"Murray","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jocn.2006.08.012_bib28","first-page":"705","article-title":"Automatic drug use audit in primary care: a pilot evaluation of warfarin use for patients with atrial fibrillation","volume":"34","author":"Mortimer","year":"2005","journal-title":"Aust Fam Physician"},{"key":"10.1016\/j.jocn.2006.08.012_bib29","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1161\/01.STR.0000115528.53718.1B","article-title":"Ximelagatran or warfarin for stroke prevention in patients with atrial fibrillation?","volume":"35","author":"Hankey","year":"2004","journal-title":"Stroke"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586807000148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586807000148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T02:58:34Z","timestamp":1557111514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586807000148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0967586807000148"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2006.08.012","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}